Success Stories
February 2026

Lyon T6 tramway line extension

The extension of Lyon’s T6 tramway line has officially entered service.

As part of this major infrastructure project for the Lyon Metropolitan Authority, Systerel worked alongside Equans Ineo UTS on the line extension, particularly at the Villeurbanne stations and the Doua campus.

Company
December 2025

Systerel supports blood donation

We actively support our employees who choose to donate blood.

To make this process easier, our teams can benefit from the shuttle service provided by the French Blood Establishment, during work hours.

Success Stories
November 2025

Systerel Develops DMI for HSR in South Korea

As part of the rollout of new high-speed trains on the South Korean rail network, Compagnie des Signaux, responsible for onboard equipment, entrusted Systerel with developing the software for the Driver Machine Interface (DMI).

This new collaboration builds on a relationship of trust developed through numerous projects completed together, both in France and internationally.

Company
November 2025

Systerel participates in Industry Week with Elles Bougent

As part of Industry Week, we welcommed a group of young girls from the Sophie Germain middle school in Aix-en-Provence. They joined us for an afternoon of insightful exchanges.

Together with the Elles Bougent association, we were able to showcase the wide range of careers in engineering and IT. Our goal was to inspire vocations and encourage diversity in these fields.

Projects
November 2025

Post-Quantum Cryptography OPC UA Initiative

Systerel is proud to take part in a European initiative on Post-Quantum Cryptography (PQC) and OPC UA.

This project anticipates future cybersecurity risks by developing solutions that will keep industrial systems secure in the quantum era.

Company
october 2025

Charity Run: Aix en Foulées 2025

The Systerel team laced up their sneakers once again to take part in Aix en Foulées 2025, a charity race benefiting two organizations that support children facing severe health challenges.